{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:08:53Z","timestamp":1785863333156,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":511,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.fertnstert.2020.07.023","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T13:24:23Z","timestamp":1602854663000},"page":"229-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A patient-specific model combining antim\u00fcllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-6781","authenticated-orcid":false,"given":"Stylianos","family":"Vagios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn E.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin R.","family":"Sacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Bormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Souter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2020.07.023_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/jog.12685","article-title":"Prevalence of conditions causing chronic anovulation and the proposed algorithm for anovulation evaluation","volume":"41","author":"Chandeying","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bmj.327.7414.546","article-title":"Anovulation","volume":"327","author":"Hamilton-Fairley","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bpobgyn.2016.03.009","article-title":"Diagnostic criteria for PCOS: is there a need for a rethink?","volume":"37","author":"Dewailly","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2015.01.007","article-title":"The role of anti-m\u00fcllerian hormone in the classification of anovulatory infertility","volume":"186","author":"Lie Fong","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib7","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014Part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib9","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fertnstert.2019.03.002","article-title":"Associations of different molecular forms of antim\u00fcllerian hormone and biomarkers of polycystic ovary syndrome and normal women","volume":"112","author":"Wissing","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2011.06.016","article-title":"Evaluation of serum antim\u00fcllerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea","volume":"96","author":"Li","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-m\u00fcllerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib14","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/humrep\/dep225","article-title":"The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome","volume":"24","author":"Nardo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib15","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1210\/jc.2009-2106","article-title":"Serum anti-m\u00fcllerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism","volume":"95","author":"Park","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2009.03614.x","article-title":"Association of insulin resistance with anti-M\u00fcllerian hormone levels in women without polycystic ovary syndrome (PCOS)","volume":"72","author":"Park","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/humrep\/deu076","article-title":"The role of AMH in anovulation associated with PCOS: a hypothesis","volume":"29","author":"Homburg","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/humrep\/deh560","article-title":"The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea","volume":"20","author":"Jonard","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib19","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.fertnstert.2005.10.057","article-title":"Serum anti-m\u00fcllerian hormone levels in women with secondary amenorrhea","volume":"85","author":"La Marca","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib20","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1210\/jc.2012-1836","article-title":"Polycystic ovary-like abnormalities (PCO-L) in women with functional hypothalamic amenorrhea","volume":"97","author":"Robin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.rbmo.2018.08.012","article-title":"Towards international standardization of immunoassays for m\u00fcllerian inhibiting substance\/anti-m\u00fcllerian hormone","volume":"37","author":"Ferguson","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib22","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib23","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/humrep\/dex239","article-title":"Use of the serum anti-m\u00fcllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome","volume":"32","author":"Fraissinet","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MOP.0000000000000636","article-title":"An update on PCOS in adolescents","volume":"30","author":"Fitzgerald","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.fertnstert.2017.07.005","article-title":"Polycystic ovary morphology: age-based ultrasound criteria","volume":"108","author":"Kim","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4103\/2230-8210.167548","article-title":"Can anti-m\u00fcllerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress","volume":"19","author":"Singh","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/cen.13934","article-title":"Exploration of the role of anti-m\u00fcllerian hormone and LH\/FSH ratio in diagnosis of polycystic ovary syndrome","volume":"90","author":"Le","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2017.01.017","article-title":"Obesity and female infertility: potential mediators of obesity\u2019s impact","volume":"107","author":"Broughton","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-m\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00404-018-4803-8","article-title":"The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-m\u00fcllerian hormone","volume":"298","author":"Casadei","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12020-018-1555-y","article-title":"Influence of body mass index in anti-m\u00fcllerian hormone levels in 951 non-polycystic ovarian syndrome women followed at a reproductive medicine unit","volume":"61","author":"Simoes-Pereira","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2011.06.006","article-title":"Is the plasma anti-m\u00fcllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?","volume":"158","author":"Skalba","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.fertnstert.2010.11.062","article-title":"Women, weight, and fertility: the effect of body mass index on the outcome of superovulation\/intrauterine insemination cycles","volume":"95","author":"Souter","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib34","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.fertnstert.2005.02.052","article-title":"Serum m\u00fcllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome","volume":"84","author":"Siow","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib35","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-m\u00fcllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00404-012-2363-x","article-title":"Is there any correlation between AMH and obesity in premenopausal women?","volume":"286","author":"Sahmay","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12020-018-1756-4","article-title":"The relationship between anti-m\u00fcllerian hormone serum level and body mass index in a large cohort of infertile patients","volume":"63","author":"Albu","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.fertnstert.2016.10.009","article-title":"Antimullerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome","volume":"107","author":"Feldman","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2014.03.032","article-title":"Age-specific serum antimullerian hormone levels in women with and without polycystic ovary syndrome","volume":"102","author":"Cui","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.rbmo.2017.05.013","article-title":"Effect of obesity and its related metabolic factors on serum anti-m\u00fcllerian hormone concentrations in women with and without polycystic ovaries","volume":"35","author":"Lefebvre","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10815-015-0540-0","article-title":"Antim\u00fcllerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome","volume":"32","author":"Kriseman","year":"2015","journal-title":"Journal of assisted reproduction and genetics"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib42","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jc.2008-2648","article-title":"Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women","volume":"94","author":"Robker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jri.2011.01.008","article-title":"Inflammatory pathways linking obesity and ovarian dysfunction","volume":"88","author":"Robker","year":"2011","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib44","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/humrep\/det072","article-title":"Leptin suppresses anti-m\u00fcllerian hormone gene expression through the JAK2\/STAT3 pathway in luteinized granulosa cells of women undergoing IVF","volume":"28","author":"Merhi","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib45","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1507\/endocrj.EJ12-0055","article-title":"Differences of the association of anti-m\u00fcllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome","volume":"59","author":"Woo","year":"2012","journal-title":"Endocr J"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib46","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/aogs.12247","article-title":"Elevated serum levels of anti-m\u00fcllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome","volume":"92","author":"Sahmay","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/09513590.2013.777415","article-title":"The role of serum anti-m\u00fcllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome","volume":"29","author":"Casadei","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib48","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/humrep\/des213","article-title":"Anti-m\u00fcllerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?","volume":"27","author":"Eilertsen","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib49","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-m\u00fcllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib50","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation with polycystic ovaries but not overt hyperandrogenism","volume":"91","author":"Dewailly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib51","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/569862","article-title":"Phenotype and metabolic disorders in polycystic ovary syndrome","volume":"2012","author":"Gluszak","year":"2012","journal-title":"ISRN Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/humrep\/det034","article-title":"A prediction model to select PCOS patients suitable for IVM treatment based on anti-m\u00fcllerian hormone and antral follicle count","volume":"28","author":"Guzman","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.07.023_bib53","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-m\u00fcllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220306762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220306762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:28:12Z","timestamp":1758011292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028220306762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0015028220306762"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.07.023","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A patient-specific model combining antim\u00fcllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92020 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}